NTLA
Intellia Therapeutics, Inc. · Healthcare
EVP and General Counsel James Basta sold $48K of Intellia Therapeutics, Inc.
Sold$47,741
$43.88Price
1,088Shares
−2%Stake
What NTLA did after the filing
- The stock from Fri, Mar 3 close, $43.39
- −9.5%
- S&P 500, same days
- +2.8%
Measured over 30 trading days, to the Apr 17 close.
Traded Thu, Mar 2. Filed Fri, Mar 3, 12:10 PM ET, during the session. Returns use the Mar 3 close and the Apr 17 close. Not investment advice.